Although a great variety of genes and signalling pathways have been implicated in the development and progression of human lung cancer, the role of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) has become an object of intense study in epithelial lung malignancies6–8 only in the last decade6–8. This evidence concerns the gene NFKB1 and lung carcinoma.